Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer

Summary

The purpose of this work: to assess the tolerability and effectiveness of the autogemotherapy method on the basis of autologous antigen-activated dendritic cells in the treatment of patients with colorectal cancer. This technology is intended for complex treatment of patients with colorectal cancer and is aimed at preventing the occurrence and treatment of secondary foci. The need for this technology is justified by the widespread occurrence of colorectal cancer, a decrease in the average age at onset of the disease, and the chemoresistantness of locally advanced forms of cancer.

Timeline

Start

2016-09-27

Primary completion

2019-09

Completion

2019-09

Drugs

Indications